e-Drug3D 279 |
BENDROFLUMETHIAZIDE DISCONTINUED
|
cas 73-48-3 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters PPB 90 PERCENT Solubility INSOLUBLE IN WATER |
Target TARGET SODIUM CHLORIDE SYMPORTER |
DrugCentral Solute carrier family 12 member 3 UNIPROT P55017 SLC12A3 |
Download SDF file | 1,1-dioxo-3-(phenylmethyl)-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide Formula: Calculated chemical properties: MW 421.43 NB_atoms 27 XLogP 1.63 PSA 113.694 NB_HD 4 NB_HA 7 fsp3 0.20 Lipinski(0=no;1=yes) 1 |
FDA NDA 012164 (pdf not found) INN (BENDROFLUMETHIAZIDE) NATURETIN-2.5 (APOTHECON) APPROVAL= AP YEAR= 1959 DISCONTINUED NDA 018647 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) CORZIDE (KING PHARMS LLC) APPROVAL= AP YEAR= 1983 DISCONTINUED NDA 077833 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) NADOLOL AND BENDROFLUMETHIAZIDE (IMPAX LABS) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 078688 (pdf not found) INN (BENDROFLUMETHIAZIDE ; NADOLOL) NADOLOL AND BENDROFLUMETHIAZIDE (NATCO PHARMA) APPROVAL= AP YEAR= 2008 DISCONTINUED |
Other links: |